Sharp Therapeutics

Sharp Therapeutics Enterprise Value

The Enterprise Value (EV) of Sharp Therapeutics (SHRX.V) as of Nov 5, 2026 is 47.98 M USD. In the previous year, Enterprise Value (EV) was 47.98 M USD — a change of 0.00% (lower).

Enterprise Value

47.98 MUSD

YoY

0.00%

Last updated:

Enterprise Value (EV) of Sharp Therapeutics is 2025 47.98 M USD. Enterprise Value (EV) of Sharp Therapeutics was 2024 47.98 M USD. It decreases by 0.00% lower compared to the previous year.

The Sharp Therapeutics Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2021
47.90 M USD
Jan 1, 2022
47.87 M USD
Jan 1, 2023
49.17 M USD
Jan 1, 2024
47.98 M USD
Jan 1, 2025
47.98 M USD
The Sharp Therapeutics Enterprise Value history
YEAREnterprise ValueYoY
47.98 MUSD0.00%
47.98 MUSD-2.42%
49.17 MUSD+2.71%
47.87 MUSD-0.06%
47.90 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sharp Therapeutics Stock analysis

What does Sharp Therapeutics do? EVP Capital Inc is a Canada-based capital pool company headquartered in Toronto, Ontario, that identifies and evaluates assets or businesses for a qualifying transaction. The company has not commenced operations and has generated no revenue, focusing solely on potential acquisitions. It operates as a capital pool company without any current business activities or revenue streams. The company's business model centers on identifying and evaluating potential assets or businesses to complete a qualifying transaction, but it has not yet engaged in any operational activities or generated revenue. As a capital pool company, it serves as a vehicle for future acquisitions without any current revenue-generating products or services. EVP Capital Inc's primary focus is on the identification and evaluation of assets or businesses with the intent to complete a qualifying transaction. The company remains in a pre-revenue stage, having not commenced operations or generated any revenue, and operates as a capital pool company with no current business activities. Sharp Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sharp Therapeutics stock

Enterprise Value (EV) of Sharp Therapeutics is 47.98 M USD in 2025.

Enterprise Value (EV) of Sharp Therapeutics changed from 47.98 M USD to 47.98 M USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Sharp Therapeutics since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Sharp Therapeutics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Sharp Therapeutics

All Key Metrics — Sharp Therapeutics